Multi-national Study on the Interplay between COVID-19 Pandemic and Asthma

On February 20th, the European Journal of Allergy and Clinical Immunology shared the results of a multinational cohort that included 1,054 children with asthma and 505 non-asthmatic children aged between 4-18 years from 25 pediatric departments, from 15 countries globally. Consistent with other recent research, the findings were that childhood asthma outcomes, including control, were improved during the first wave of the COVID‐19 pandemic, “probably because of reduced exposure to asthma triggers and increased treatment adherence.” The researchers concluded that “The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID‐19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent.”